Chemotherapy-Related Tumour Lysis Syndrome

Files
TLS PRESENTATION Dr Busakhala.pdf (390.85 KB)
If you need an accessible version of this item, please email your request to digschol@iu.edu so that they may create one and provide it to you.
Date
2007
Authors
Busakhala, N. W.
Language
English
Embargo Lift Date
Department
Committee Members
Association of Kenya Physicians Scientific Conference (11th : Mar. 2007 : Eldoret, Kenya)
Degree
Degree Year
Department
Grantor
Journal Title
Journal ISSN
Volume Title
Found At
Association of Kenya Physicians
Abstract

Two types of tumour lysis syndrome (TLS) ; 1. Laboratory TLS: 25% increase in potassium, phosphate and uric acid, or decline in calcium from baseline. Occur within 4 days of initiating chemotherapy. Patients on standard of care. Minimum of two out of four criteria.

  1. Clinical tumour lysis syndrome: Laboratory TLS plus renal failure, cardiac arrhythmias or sudden death. A new definition has been suggested by Cairo and Bishop to include values above upper limit of normal. Study used Hande and Garrow definition.
Description
Keywords
tumour lysis syndrome, TLS, renal, cardiac, Hande and Garrow, gout, tumor, hyperkalemia, hyperphosphatemia
LC Subjects
Chemotherapy
MeSH Subjects
Tumor Lysis Syndrome, Kidney Failure, Drug Therapy, Arrhythmia
item.page.description.tableofcontents
item.page.relation.haspart
Cite As
ISSN
Publisher
Series/Report
Sponsorship
Major
Extent
Identifier
Relation
Journal
Rights
Source
Alternative Title
Type
Presentation
Number
Volume
Conference Dates
Conference Host
Conference Location
Conference Name
Conference Panel
Conference Secretariat Location
Permanent Link
https://hdl.handle.net/1805/1181
Version
Full Text Available at
This item is under embargo {{howLong}}
Collections
Kenya Association of Physicians Scientific Conference